K. Komuta

Slow N-acetyltransferase 2 genotype affects the incidence of isoniazid and rifampicin-induced hepatotoxicity.

Masako Ohno, Ichiro Yamaguchi, Itiro Yamamoto et al. · PubMed · 2000 · 255 citations

Tuberculosis Prevention, Pathology, Pharmacotherapy +19

Combination of morphological feature analysis and immunohistochemistry is useful for screening of EML4-ALK-positive lung adenocarcinoma

Ryu Jokoji, Takashi Yamasaki, Seigo Minami et al. · Journal of Clinical Pathology · 2010 · 134 citations

Cyclosporine Treatment for Polymyositis/Dermatomyositis: Is it Possible to Rescue the Deteriorating Cases with Interstitial Pneumonitis?

K. Maeda, Ryo Kimura, K. Komuta et al. · Scandinavian Journal of Rheumatology · 1997 · 93 citations

Inflammation, Rheumatology, Interstitial Pneumonitis +8

Chemotherapy-induced neutropenia as a prognostic factor in advanced non-small-cell lung cancer: results from Japan Multinational Trial Organization LC00-03

Yusuke Kishida, Mutsuto Kawahara, Satoshi Teramukai et al. · British Journal of Cancer · 2009 · 83 citations · Full text

Combined therapy of mice bearing a lymphokine-activated killer-resistant tumor with recombinant interleukin 2 and an antitumor monoclonal antibody capable of inducing antibody-dependent cellular cytotoxicity.

Ichiro Kawase, K. Komuta, Hideki Hara et al. · PubMed · 1988 · 42 citations

Immunology, Recombinant Interleukin 2, Immunologic Mechanism +19